NCT03650023View on ClinicalTrials.gov

A Crossover Trial of Chitosan Oligosaccharide on Post Prandial Glucose Control in Subjects With Normal, IFG and IGT

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 9, 2018

Primary Completion Date

July 25, 2018

Study Completion Date

July 25, 2018

Conditions
NormalImpaired Fasting GlucoseImpaired Glucose Tolerance
Interventions
DIETARY_SUPPLEMENT

Chitosan Oligosaccharide (GO2KA1)

Chitosan Oligosaccharide (GO2KA1) capsule was consumed within 15 min, and then 2-h oral sucrose tolerance test was conducted.

DIETARY_SUPPLEMENT

White egg

White egg capsule was consumed within 15 min, and then 2-h oral sucrose tolerance test was conducted.

Trial Locations (1)

03722

Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University., Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03650023 - A Crossover Trial of Chitosan Oligosaccharide on Post Prandial Glucose Control in Subjects With Normal, IFG and IGT | Biotech Hunter | Biotech Hunter